MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

SIFI

SIFI is a 71-year old, privately owned pharmaceutical company specialised in ophthalmology. The company has three main business units: Pharma, Surgical, Diagnostic.

The company in detail

Summary

SIFI is a 71-year old, privately owned pharmaceutical company specialised in the niche of Ophthalmology/Eye Care. Based in Italy, it is the leader in the domestic ophthalmic pharma market SIFI has three main business lines: Pharma, Surgical, Diagnostic. In particular, the company's business can be broken down as illustrated below: PHARMA (ophthalmic sector) - Pre-clinical and clinical development, manufacturing, marketing and sales of ethical products - Pre-clinical and clinical development, manufacturing, marketing and sales of medical devices - Development, marketing and sales of food supplements SURGICAL (ophthalmic sector) - Research, development, manufacturing, marketing and sales of surgical disposable devices DIAGNOSTIC (ophthalmic sector) Research, development, manufacturing, marketing and sales of diagnostic equipment THIRD PARTY SERVICES (ophthalmic and non ophthalmic Sector) - Contract manufacturing of ethical products and medical devices SIFI aims to become a global Eye Care Company enabling practitioners to manage a wide range of ophthalmic diseases through a complete array of solutions from diagnostic to medical and/or surgical therapies. Due to the characteristics summarised below, SIFI can be a preferred partner of choice for licensing and partnering opportunities in the Eye Care industry - 71-year long specialisation in Ophthalmology - Solid reputation within the ophthalmic/pharmaceutical community - High brand recognition - Growth-oriented mindset - Experienced management team - Leading position in Italy ahead of multinationals in the pharma business - High quality and comprehensive product list in Pharma - High end, innovative R&D pipeline the surgical and diagnostic fields - Specialised, long-established, full-time sales force - Commitment to innovation - Strong development capabilities - World-class - EEC cGMP-compliant pharmaceutical manufacturing facility. State-of-the art technology in the ophthalmic surgical and diagnostic fields - Broad network of relationships and strategic alliances with quality international partners

Senior management

To view this information, you must subscribe to PL Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us